The fight for affordable insulin

Dylan Scott, a senior correspondent at Vox, dives into the insulin pricing crisis that has left many Americans in despair. He details the heartbreaking stories behind skyrocketing costs, including the tragic loss of lives due to unaffordability. Scott discusses Eli Lilly's landmark decision to cap insulin prices at $35, examining its impact on patients and ongoing protests. The conversation highlights the historical context of insulin's discovery versus its current monopolized pricing, shedding light on the urgent need for healthcare reform.